NSAIDs DERIVATIVES AND USES THEREOF
US-2015376162-A1 · Dec 31, 2015 · US
Compositions and methods for the treatment of neurological disorders
US10208014B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10208014-B2 |
| Application number | US-201414533114-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 5, 2014 |
| Priority date | Nov 5, 2014 |
| Publication date | Feb 19, 2019 |
| Grant date | Feb 19, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to valproic acid derivatives or pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of valproic acid derivatives, and methods for treating or preventing neurological disorders may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of epilepsy, bipolar disorder, migraine, schizophrenia, depression, Alzheimer's disease, cancer, HIV and familial adenomatous polyposis.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of: or a pharmaceutically acceptable salt, enantiomer, or stereoisomer thereof.
Assignees
Inventors
Classifications
Monocarboxylic acid esters having at least two carbon-to-carbon double bonds · CPC title
- C07D339/04Primary
having the hetero atoms in positions 1 and 2, e.g. lipoic acid · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10208014B2 cover?
- The invention relates to valproic acid derivatives or pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of valproic acid derivatives, and methods for treating or preventing neurological disorders may be formulated for oral, buccal, rectal, topical, transdermal, transmu…
- Who is the assignee on this patent?
- Kandula Mahesh, Cellix Bio Private Ltd
- What technology area does this patent fall under?
- Primary CPC classification C07D339/04. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).